Om

Check-Cap Ltd. is a clinical-stage medical diagnostics company focused on capsule-based colorectal cancer screening. The company develops C-Scan, an ingestible imaging capsule system designed to detect precancerous polyps and other abnormalities in the colon using a preparation-free, non-invasive approach. Its technology is intended to support earlier identification of colorectal disease while offering a more patient-friendly alternative to traditional screening methods. Check-Cap Ltd. operates in the health technology and medical devices space, serving the growing demand for accessible diagnostic tools in preventive care. The company is based in Isfiya, Israel, and its current business centers on advancing screening solutions for clinical use and broader adoption in colorectal health management.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I MBODY AI MED ENDAVU: Køb MBody AI ($7CC) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i MBody AI, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.